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Abstract
Background:  Beyond the classic Normal Pressure Hydrocephalus (NPH) triad of gait disturbance,
incontinence, and dementia are characteristic signs of motor dysfunction in NPH patients. We used highly
sensitive and objective methods to characterize upper limb extrapyramidal signs in a series of NPH
subjects compared with controls. Concentrated evaluation of these profound, yet underappreciated
movement disorders of NPH before and after techniques of therapeutic intervention may lead to
improved diagnosis, insight into pathophysiology, and targeted treatment.
Methods: Twenty-two (22) consecutive NPH patients and 17 controls performed an upper limb motor
task battery where highly sensitive and objective measures of akinesia/bradykinesia, tone, and tremor were
conducted. NPH subjects performed this test battery before and more than 36 h after continuous CSF
drainage via a spinal catheter over 72 h and, in those subjects undergoing permanent ventriculo-peritoneal
shunt placement, at least 12 weeks later. Control subjects performed the task battery at the same dates
as the NPH subjects. Statistical analyses were applied to group populations of NPH and control subjects
and repeated measures for within subject performance.
Results: Twenty (20) NPH subjects remained in the study following CSF drainage as did 14 controls. NPH
subjects demonstrated akinesia/bradykinesia (prolonged reaction and movement times) and increased
resting tone compared with controls. Furthermore, the NPH group demonstrated increased difficulty with
self-initiated tasks compared with stimulus-initiated tasks. Following CSF drainage, some NPH subjects
demonstrated reduced movement times with greater improvement in self- versus stimulus-initiated tasks.
Group reaction time was unchanged. Resting tremor present in one NPH subject resolved following shunt
placement. Tone measures were consistent for all subjects throughout the study.
Conclusion: Clinical motor signs of NPH subjects extend beyond gait deficits and include extrapyramidal
manifestations of bradykinesia, akinesia, rigidity, and propensity to perform more poorly when external
cues to move are absent. Objective improvement of some but not all of these features was seen following
temporary or permanent CSF diversion.
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Background
The classic clinical triad of Normal Pressure Hydrocepha-
lus (NPH) includes gait disturbance, incontinence, and
dementia though most patients exhibit less than three of
these signs early in the progressive clinical course [1,2]. In
addition to classic gait abnormalities, NPH patients
exhibit other motor deficits including those affecting the
upper limbs. Extrapyramidal motor signs in NPH patients
include Parkinsonian and Huntingtonian movements,
and these signs may reverse following therapeutic cerebro-
spinal fluid (CSF) drainage [3,4].
That ventriculo-peritoneal shunting reverses each of the
classic signs in some NPH patients suggests a causative
role in CSF dynamics, but the mechanisms underlying the
neuronal and glial pathophysiology of NPH remain
obscure. During the course of NPH, periods of elevated
intracranial CSF pressure are hypothesized to result in
dysfunction of white and gray matter of the brain (includ-
ing basal ganglia) [5]. These hypotheses are supported by
functional imaging studies as well as post-mortem patho-
logic analysis of brain parenchyma [2,6-8]. At the time of
diagnosis, CSF pressures may be "normal" with accom-
modating ventricular enlargement over time; alterna-
tively, intermittently elevated pressures may go
undetected in NPH unless continuous CSF pressure mon-
itoring is performed [9].
Few investigations of NPH patients have included objec-
tive and sensitive analysis of extrapyramidal motor signs,
and examination of these signs outside of gait dysfunction
are rarer still [3,10-12]. We sought to examine a series of
subjects referred for evaluation of possible NPH at base-
line, following CSF drainage via spinal catheter and again
following placement of a permanent ventriculo-perito-
neal shunt using objective, sensitive measures of extrapy-
ramidal motor signs. Using a battery of non-invasive tests,
we report our results of upper extremity movement initia-
tion and execution, tone and tremor measures during
baseline and following these therapeutic interventions.
Control cohorts were examined using the same testing
battery but without any intervention. The results of these
studies should serve as a basis for insight into the mecha-
nisms of disease, improve clinical recognition and objec-
tively demonstrate features of upper extremity motor
performance improvement following potential therapeu-
tic intervention.
Methods
Demographics
This study, together with patient recruitment, was
approved by the Johns Hopkins University Institutional
Review Board. Signed, informed consent was obtained
from each subject. Twenty-two (22) consecutive subjects
above the age of 50 (average age 74.7; range 51 – 85 years)
referred for evaluation of possible NPH were recruited
from the Johns Hopkins University Outpatient Center,
with no enrollment restrictions based on race or ethnic
origin. Requirements for inclusion were radiographic evi-
dence of ventriculomegaly by CT scan or conventional
MRI, and clinical signs of NPH that included gait impair-
ment, urinary incontinence, or cognitive impairment.
Subjects were excluded if they had undergone prior shunt
or intracranial surgery, were unable to undergo lumbar
puncture for CSF drainage or had other active neurologic
disease (stroke, Parkinson's disease, Alzheimer's disease,
CNS infection, blindness, myelopathy or amputation).
Controls (n = 17) were partners of eligible NPH subjects
(average age 70; range 57 – 79 years) and were required to
be free from clinical signs of NPH.
NPH subjects were tested with the entire battery of tasks at
1) baseline, 2) within 36 h following removal of approxi-
mately 10 ml CSF/h for 72 h via a temporary spinal cath-
eter and 3) approximately 12 weeks following ventriculo-
peritoneal shunt insertion (Medtronic). Control subjects
were tested with the entire battery of tasks on the same
days of testing as NPH subjects. Two NPH subjects dem-
onstrated signs of infection following CSF drainage via
spinal catheter and were excluded from further testing and
analysis. One subject withdrew consent to participate in
the study after baseline testing such that subsequent data
were not collected.
Volitional motor tasks
Subjects performed ballistic movements using their dom-
inant hand by moving a manipulandum that constrained
two-dimensional movement about the wrist. Targets, 10°
wide and unbounded (to require precision in holding ini-
tial and final target positions), were separated by 50°.
Practice trials were performed for this simple task to avoid
any potential learning curve barriers. Subjects reacted and
moved in response to an auditory "GO" signal (stimulus-
initiated tasks) or performed the identical movement task
in the absence of a "GO" signal (self-initiated tasks). All
subjects were informed ahead of time if they were to per-
form stimulus- or self-initiated tasks, and in both cases
received preparatory auditory cues of "ready" and "set" in
the initial stages of the task. In stimulus-initiated tasks,
these preparatory cues preceded randomly delivered
"GO" signals, and in self-initiated tasks, where no "GO"
signal was delivered, a minimum time of 2 s of hold time
was required after the "set" cue before initiating move-
ment. Errors were recorded and the task discarded if
movement occurred prior to 150 ms more than "GO" sig-
nal, more than 1 s after the "GO" signal, or if final target
was overshot. An electronic goniometer continuously
recorded manipulandum position during the task and
was fed into an online recording computerized system
(Biopac Systems, CA) along with auditory cues and elec-Cerebrospinal Fluid Research 2007, 4:7 http://www.cerebrospinalfluidresearch.com/content/4/1/7
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tromyographic recordings of agonist and antagonist wrist
muscles performing the task. Forty-five correctly per-
formed trials were performed by each of the subjects.
Reaction time (RT) was measured as time between "GO"
signal and first significant change of the agonist electro-
myographic record (EMG) over baseline (RT/EMG) and
between "GO" signal and movement onset (MO) (RT/
MO). Electromechanical delay (EMD) was determined as
the time between first agonist EMG and movement onset.
Movement time (MT) was defined as the time between
movement onset (MO) and achieving final target.
Tone measures
Muscle tone was measured by an apparatus that quantifies
tone about the elbow. Subjects rested their dominant fore-
arm in a molded and padded cradle mounted on a metal
beam. The cradle rotated on low-friction ball bearings and
an electronic goniometer measured angular displacement.
A load cell (Biopac Systems, CA) located at the side of the
metal beam measured the torque applied by the exam-
iner. The torque plotted against the angle (degrees) repre-
sented muscle stiffness, and post-hoc least squares fit
analysis was then performed to determine the slope of the
contour representing tone about the elbow [13]. The tone
apparatus allowed the examiner to test the arm using
movements similar to that during a clinical exam,
whereby the examiner flexes and extends the patient's
elbow while at repose. Data were rejected if there was
active resistance or assistance by the patient as in 'gegen-
halten', which was detected by aberrations in the slope of
the stiffness (stiffness constant k = the slope of force over
displacement), or active EMG activity in primary agonists
or antagonists about the elbow [13]. Three data sets of
continuous, repetitive arm flexion and extension motion
were obtained from each subject until a reproducible trace
was obtained [13].
Tremor analysis
Tremor was analyzed using triaxial solid-state accelerom-
eters (Biopac Systems, CA) that detect frequency (Hz) and
amplitude (root mean square horizontal and vertical dis-
placements) in µm. Triaxial accelerometers were placed
on the distal hand while the subjects' hands were at repose
for a period of 120 s. Subjects were then asked to hold
their arms outstretched, and tremor analysis was repeated
during the next 60 s. All data were fed online to a Pentium
based computer and analyzed using Fast Fourier Trans-
forms. Mean tremor amplitude and dominant frequency
were recorded while at rest and with outstretched arms.
Statistical methods
Group statistical analyses for parametric measures were
compared using ANOVA tests with Fisher's Least Square
Difference Post-Hoc analysis when F scores were signifi-
cant or Kruskal-Wallis comparisons for non-parametric
measures of reaction time. Analyses within individuals
were compared using Repeated-measures ANOVA with
Fisher's Least Square Difference or Friedman's analysis
with Mann-Whitney Post-Hoc analysis.
Results
Simple reaction time
As a group, NPH subjects demonstrated modest but sig-
nificant prolongation of reaction time measured either as
RT/EMG (controls: 170.0 ± 39 ms v/s NPH subjects: 233.8
± 34 ms; median ± SD; p < 0.01), or as RT/MO (controls:
299.0 ± 38 ms v/s NPH subjects: 345.8 ± 39 ms; median ±
SD; p  < 0.01) when compared with the control group
(Table 1). However, there is overlap between individual
controls and NPH subjects in RT measures (range for con-
trols: 245.3 – 361.3 ms; range for NPH: 282.8 – 434.2
ms). Few NPH subjects demonstrated significant reduc-
tions in RT whether measured by RT/MO or RT/EMG fol-
lowing CSF drainage and equally few demonstrated
prolonged RTs (p < 0.05; Friedman's analysis) (Figure 1).
As a group, the change in RT/MO was similar to that of
RT/EMG, but for a few subjects the improvement in RT/
EMG exceeded that for RT/MO. This suggests for these few
subjects that pure reaction time decreased as measured
from "GO" signal to agonist EMG activity, but electrome-
chanical delay prevented decreased movement initiation
latency. This was likely caused either by co-contraction
(antagonist muscle activity interfered with movement ini-
tiation) or less than optimal muscle organization prevent-
ing earlier movement-initiation. Controls did not reveal
significant changes in RT measures on repeat visits.
Ballistic movement times
As a group, NPH subjects demonstrated prolonged MT
versus controls (Table 1). At baseline, a subset of NPH
subjects demonstrated significantly prolonged movement
times when required to make self-initiated compared with
stimulus-initiated movements to an unbounded target
(repeat measures ANOVA; p  < 0.02; F = 3.824). Mean
Table 1: Overview of grouped data represented as means of medians (RT) or means of means (MT; Tone) ± SEM. (When taken as a 
group, NPH subjects performed differently from control subjects in each measure; ** p < 0.01, * p < 0.05).
RT/EMG (ms) RT/MO (ms) Stim MT (ms) Self MT (ms) Tone (k)
Controls 170.0 ± 39 299.0 ± 38 493 ± 15 513 ± 18 .0012 ± .0003
NPH 233.8 ± 34** 345.8 ± 39** 554 ± 26** 628 ± 39** .0055 ± .0010*Cerebrospinal Fluid Research 2007, 4:7 http://www.cerebrospinalfluidresearch.com/content/4/1/7
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movement times for stimulus-initiated and self-initiated
tasks are plotted for each NPH subject at baseline in Figure
2. Approximately 40% of NPH subjects exhibit this behav-
ior that self-initiated tasks were prolonged compared with
stimulus-initiated tasks, whereas less than 15% of control
subjects exhibited this behavior. The absolute magnitude
of this discrepancy is greatly enhanced in NPH compared
with those controls that exhibit minor differences
between self- and stimulus-initiated motor behavior.
Those NPH subjects with fastest movement times (least
bradykinetic) were least apt to exhibit discrepancies
between self- and stimulus-initiated movements. Further-
more, those NPH subjects with fastest movement times
were least apt to exhibit wide intertrial movement time
variability as reflected by size of error bars (Figure 2).
Following CSF drainage, NPH subjects demonstrated
improvement in self-initiated tasks as compared with
stimulus-initiated tasks (5 of 19 subjects; repeat measures
ANOVA; p < 0.05), but this did not hold true for the group
analysis comparing NPH subjects before and after contin-
uous CSF drainage (Figure 3). Figure 3 reflects that NPH
subjects exhibit overall bradykinesia compared with con-
trols as well as an increased propensity of NPH subjects to
perform more poorly on self-initiated tasks compared
with stimulus-initiated tasks.
Based on the clinical response to CSF drainage, some NPH
subjects were offered and elected to receive placement of
a ventriculoperitoneal shunt (n = 12). Those subjects
demonstrating significant differences of movement times
from baseline following CSF drainage maintained this dif-
ference following shunt placement. Furthermore, selective
improvement of self- versus stimulus-initiated movement
times persisted with shunt placement (Figure 4). Control
subjects did not demonstrate significantly different per-
formances on any of the motor tasks with repeated meas-
ures on subsequent visits, compared to baseline (repeat
measures ANOVA
Rigidity in NPH
Tone measures at baseline demonstrate increased passive
tone about the elbow in NPH subjects compared with
control cohorts (p < 0.02, Table 1, Figure 5). The source of
increased resting tone was not spasticity or gegenhalten.
Consistency of tone testing within all subjects was sup-
ported by consistent hysteresis loops of force versus dis-
tance with highly correlative measures between testing on
different days for controls (linear regression; p < 0.02, R2
= 0.79). Following CSF drainage and following shunt
placement, there were also no significant changes in slope
(representing rigidity at the elbow) for the NPH subjects.
However, there were qualitative differences in tone hyster-
esis loops following CSF drainage in NPH subjects includ-
ing greater incidence in EMG activity and sudden tone
perturbations in the NPH group not seen in control sub-
jects.
Movement time in NPH Figure 2
Movement time in NPH. Plot of stimulus-initiated (gray 
bars) and self-initiated (black bars) movement times (MT) of 
each NPH subject at baseline in s (mean ± SEM; n = 45). A 
subset of subjects demonstrated statistically prolonged 
movement times during the self-initiated tasks compared 
with stimulus-initiated tasks. Vertical arrows indicate those 
NPH subjects who later underwent shunt placement.
Reaction time in NPH Figure 1
Reaction time in NPH. Plot of Reaction times to move-
ment onset (RT/MO) for each NPH subject at baseline (gray 
bars) and following CSF removal (black bars; n = 45). Data 
are median values ± standard deviation in s. No significant 
differences were demonstrated in NPH RTs following CSF 
drainage via a temporary spinal catheter (nor later by VP 
shunt). Vertical arrows indicate those NPH subjects who 
later underwent shunt placement.Cerebrospinal Fluid Research 2007, 4:7 http://www.cerebrospinalfluidresearch.com/content/4/1/7
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Correlations between increased rigidity and bradykinesia
were poor amongst NPH subjects, such that these seem to
be expressed independently within subjects. Similarly,
improvements in bradykinesia were not reflected in
reductions in rigidity following therapeutic interventions.
Tremor studies
Controls and NPH subjects were largely without detecta-
ble tremors either at rest or with sustained arm postures.
The exceptions were in two NPH subjects who demon-
strated low amplitude, low frequency tremor. Of the two
subjects with tremor, following shunt placement, rest
tremor was no longer detectable in one subject. Even with
the highly sensitive accelerometer, tremor did not appear
in the majority of NPH subjects tested.
Correlation with classic NPH parameters
In a parallel study, these same subjects underwent formal
gait analysis (Williams et al, unpublished data). Although
some subjects improved in both gait and upper extremity
measures, this was not uniformly so – such that substan-
tial improvement in gait measures did not always coincide
with improvement in ballistic measures. Since none of the
subjects improved in measures of tone, improvement in
gait did not correlate with this measure. Interestingly,
some of those subjects that demonstrated increased upper
extremity bradykinesia following CSF drainage also dem-
onstrated worsening bradykinesia in gait testing.
Discussion
Objective assessment of upper limb movement perform-
ance is lacking for NPH subjects. No prior study of objec-
tive, quantifiable measures of tone in NPH subjects has
been reported. Using our sensitive measures we detected
bradykinesia, akinesia and increased tone in NPH subjects
compared with controls. By our novel testing paradigms
in NPH subjects employing both stimulus- and self-initi-
ated tasks, we also found that some NPH subjects demon-
strate the classic Parkinsonian motor characteristic of
improved movement execution in the presence of external
cues. Following CSF drainage by temporary spinal cathe-
ter or permanent shunt placement, bradykinesia seemed
most amenable to improvement. In NPH subjects, motor
performance in self-initiated tasks showed greater dys-
function at baseline than with stimulus-initiated tasks,
and demonstrated more dramatic improvement following
CSF drainage.
There are several anecdotal reports of NPH causing Par-
kinsonian motor behavior [4,14,15]. While it may be
argued that these patients may have both NPH and idio-
pathic Parkinson's disease, reversal of these signs with CSF
drainage and the general failure of these patients to
improve with levodopa therapy argues against dual diag-
noses. Our more detailed and sensitive investigation of
arm motor performance demonstrated that a majority of
NPH subjects exhibit Parkinsonian signs, with bradyki-
Self-initiated movement in NPH Figure 4
Self-initiated movement in NPH. Raw data plots of the 
12 NPH patients who received V-P shunt during self-initiated 
movement time (MT) tasks. The Y axis represents time in s, 
separate patients are plotted on the X axis with MT from 
baseline measure (gray squares) and following V-P shunt 
placement (open circles). Those subjects that demonstrated 
changes in MTs (whether prolonged or decreased) with CSF 
drainage, demonstrated similar changes from baseline. (For 
comparison, average control self-initiated movement times 
were 513 ± 18 ms).
Combined movement time in control and NPH subjects Figure 3
Combined movement time in control and NPH sub-
jects. Plot of mean combined movement times (s) of all Con-
trol and NPH subjects at baseline and at a time following CSF 
drainage in NPH subjects with controls retested at the same 
time (means ± SEM). As a group, NPH subjects were 
bradykinetic compared with controls and demonstrated 
greater disparity between self- and stimulus-initiated move-
ment times. As a group, no significant improvement was seen 
in MTs following CSF drainage in NPH subjects, but repeat 
measures analysis demonstrated significant improvement in a 
subgroup.Cerebrospinal Fluid Research 2007, 4:7 http://www.cerebrospinalfluidresearch.com/content/4/1/7
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nesia being most common. Other uncommon extrapy-
ramidal presentations in NPH include Huntingtonian
signs that may reverse following shunt surgery [16]. These
reports and our data suggest that extrapyramidal pathways
are often affected in NPH pathophysiology.
Although NPH has been formally described for over 4 dec-
ades, the pathophysiology and etiology underlying this
disorder remain obscure. Several hypotheses exist for the
motor manifestations of the disease. The derangement of
anatomical structures from increased ventricular size is
thought to exert shearing forces on underlying paren-
chyma [5]. Those structures immediately adjacent to
enlarged ventricles may be subjected to the greatest stress.
Since subcortical white matter corresponding to leg motor
fibers are most medial, it is suggested that these may be
most adversely influenced. However, it is clear by this and
other studies that NPH subjects exhibit signs beyond gait
problems, including a variety of extrapyramidal signs [4].
In this study, the NPH subjects as a group demonstrated
akinesia, bradykinesia and increased tone compared with
controls.
White matter influences on extrapyramidal loops, or on
connections in premotor processing theoretically explain
these Parkinsonian signs. However, there is evidence in
NPH post mortem analyses that deep brain nuclei
involved in extrapyramidal motor control are also directly
affected. Indeed, although some PET studies suggest white
matter dysfunction in NPH as inferred from reduced cere-
bral blood flow, there are conflicting studies throughout
the literature to these findings [6,8,17]. At least one recent
PET analysis suggested a predominance of basal ganglia
dysfunction on PET in NPH subjects [17]. Anatomical
studies on post-mortem NPH brains also demonstrate
pathologic change in both white matter as well as basal
ganglia parenchyma [7]. It is hypothesized that shearing
forces may have direct and indirect influences upon brain
parenchyma [5]. Shearing stress may compromise tissue
function directly, but may also underlie a process of small
vessel hyalinization to cause later dysfunction; this may
occur especially in those basal ganglia structures most at
risk for this process [5,7].
No correlations exist between baseline presentation of
tone, akinesia or bradykinesia (whether examining self- or
stimulus-initiated movements) in NPH subjects. This
implies that different pathophysiological substrates
underlie each of these motor signs in NPH, and/or that
these signs emerge independently. Of these extrapyrami-
dal signs, not all respond equally to CSF drainage. Why
would only some symptoms respond to CSF drainage? It
is plausible that some structures revert to normal function
with reduction of direct shearing forces, while others (say
with ischemia from small vessel hyalinization) are irre-
versible or require time for tissue recovery or compensa-
tory pathways to develop. In addition, there is always a
potential for multiple etiologies to confound the presen-
tation and responsiveness of clinical signs related to NPH,
but our selection criteria sought to minimize these factors.
It is an interesting finding that some NPH patients dem-
onstrated the classic Parkinsonian motor characteristic of
improved movement execution in the presence of external
cues. Others have seen a less dramatic benefit of external
cues when studying NPH patients during gait analysis
[10,18]. Our study design sought to include direct com-
parison of self- and stimulus-initiated movements to
directly examine the influence of external cues in motor
performance. The underlying mechanism of improved
motor performance with external cues in Parkinsonism is
suggested to arise from dysfunction of the supplementary
motor area (SMA). The SMA is credited with motor initia-
tion and planning of movement and is disrupted in Par-
kinsonism [19]. This cortical structure is dependent upon
basal ganglia input via thalamus and in turn has direct
influence over other premotor areas as well as the primary
motor cortex. Furthermore, the SMA is anatomically situ-
ated similar to the leg homunculus representation of the
primary motor cortex, readily susceptible in its subcortical
projection and receiving fibers to potential shearing forces
from ventricular enlargement as seen in NPH. Future cor-
relations of our objective, sensitive neurophysiological
measures with pathological and advanced imaging tech-
Tone analysis in NPH versus control subjects Figure 5
Tone analysis in NPH versus control subjects. Plots of 
the slope of the line of force: angular displacement about the 
elbow (stiffness constant k) for control and NPH subjects at 
baseline during repose. Solid diamonds represent each indi-
vidual subject, and horizontal lines denote mean values. As a 
group, NPH patients displayed significantly increased tone 
versus controls (p < 0.02) with a majority of subjects demon-
strating tone outside the range of controls.Cerebrospinal Fluid Research 2007, 4:7 http://www.cerebrospinalfluidresearch.com/content/4/1/7
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niques may help correlate specific SMA and surrounding
structure dysfunction with increased bradykinesia during
self-initiated movements. In addition, this may lead to
better predictive value of patient improvement with ther-
apeutic interventions related to CSF flow.
NPH subjects demonstrate increased tone compared with
controls. This tone is unrelated to spasticity and inde-
pendent of movement speed. Our measures of tone are
highly sensitive, and even a significant increase in tone
compared with controls may be subclinical. From what is
known of NPH, one would expect a supraspinal mecha-
nism underlying increased tone. Such mechanisms have
been proposed for the increased tone seen in Parkinson-
ism [20]. There was no correlation between increased tone
and the presence of other extrapyramidal features at base-
line in NPH subjects. Measures of tone did not improve
following CSF drainage. Thus neuronal pathways, other
than those directly relieved by CSF drainage may be
responsible for rigidity in NPH, or those contributing
underlying factors contributing to tone are relatively non-
reversible, say by ischemic changes.
Conclusion
The underlying motor pathophysiology of NPH signs
extends beyond gait and bladder dysfunction with preva-
lence of extrapyramidal signs. These include even complex
Parkinsonian signs of reliance upon external cues for
improved motor performance. That NPH subjects demon-
strated improvement of some signs in short order follow-
ing CSF drainage suggests reversible pathophysiologic
mechanisms that can improve activities of daily living.
However, sensitive and objective motor measures in this
sample suggest other motor dysfunction is resistant to
immediate correction by CSF drainage and may be recal-
citrant or require chronic treatment to see improvement.
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